With lifestyle-related illnesses rising in tandem with higher standards of living and longer life spans, the drug
industry is playing an increasingly important role within the healthcare sector.
Advances in health screening probably offer the most immediate prospect of reducing the cancer-related death
rate substantially. However, prevention and screening can never be perfectly effective as the full-blown malignant
disease will continue to be commonplace—and in need of treatment—for many years to come.
In the inaugural Symposium for Cancer, key biomedical practitioners, pharmaceutical professionals and major
industry players will convene to share and discuss their latest breakthroughs in cancer research, stem cells and
genetic treatment, genetic risk factors, early detection, new techniques and tools for diagnostics, applications,
preventive and rehabilitation care.
Join us as we discover the prospect of finding cures for the most common forms of cancer!